Cargando…

The role of procalcitonin in differential diagnosis between acute radiation pneumonitis and bacterial pneumonia in lung cancer patients receiving thoracic radiotherapy

Acute Radiation Pneumonitis (ARP) is one of the most common dose-limiting toxicities of thoracic radiotherapy. The accurate diagnosis of ARP remains a challenge because of the lack of a rapid biomarker capable of differentiating ARP from bacterial pneumo (BP). The aim of this study was to investigat...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Zhiwu, Huo, Bingjie, Wu, Qiong, Dong, Liang, Fu, Haoyu, Wang, Shuo, Zhang, Jing
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7031357/ https://www.ncbi.nlm.nih.gov/pubmed/32076108 http://dx.doi.org/10.1038/s41598-020-60063-w

Ejemplares similares

Early differential diagnosis model for acute radiation pneumonitis based on multiple parameters
por: Wang, Zhiwu, et al.
Publicado: (2020)

A novel nomogram containing acute radiation esophagitis predicting radiation pneumonitis in thoracic cancer receiving radiotherapy
por: Tang, Wenjie, et al.
Publicado: (2021)

Pneumonitis in Patients Receiving Thoracic Radiotherapy and Osimertinib: A Multi-Institutional Study
por: Banla, Leou Ismael, et al.
Publicado: (2023)

Radiation recall pneumonitis induced by chemotherapy after thoracic radiotherapy for lung cancer
por: Ding, Xiao, et al.
Publicado: (2011)

Comprehensive Pneumonitis Profile of Thoracic Radiotherapy Followed by Immune Checkpoint Inhibitor and Risk Factors for Radiation Recall Pneumonitis in Lung Cancer
por: Lu, Xiaotong, et al.
Publicado: (2022)

Establishment and Verification of a Prediction Model for Symptomatic Radiation Pneumonitis in Patients with Esophageal Cancer Receiving Radiotherapy
por: Yang, Liu-Ting, et al.
Publicado: (2021)

Are there overlapping clinical features between thoracic radiotherapy side effects and covid-19 pneumonia? Radiation pneumonitis outside the radiation ports: Three case reports
por: Lazzari, Grazia, et al.
Publicado: (2020)

Relationship between radiation pneumonitis and organizing pneumonia after radiotherapy for breast cancer
por: Oie, Yumi, et al.
Publicado: (2013)

Overlap time is an independent risk factor of radiation pneumonitis for patients treated with simultaneous EGFR-TKI and thoracic radiotherapy
por: Jia, Wenxiao, et al.
Publicado: (2021)

Comparison of the Incidence Rate of Radiation Pneumonitis Observed in Patients with Advanced Lung Adenocarcinoma Treated with Simultaneous Thoracic Radiotherapy and 1G/2G/3G EGFR-TKIs
por: Mu, Fengchun, et al.
Publicado: (2023)

Diabetes mellitus is a predictive factor for radiation pneumonitis after thoracic radiotherapy in patients with lung cancer
por: Kong, Moonkyoo, et al.
Publicado: (2019)

Radiation Pneumonitis after Radiotherapy of Neck Lymphoma
por: Wei, Min, et al.
Publicado: (2014)

Symptomatic Radiation Pneumonitis in NSCLC Patients Receiving EGFR-TKIs and Concurrent Once-daily Thoracic Radiotherapy: Predicting the Value of Clinical and Dose-volume Histogram Parameters
por: YANG, Xuexi, et al.
Publicado: (2022)

Brief Report: Severe Pneumonitis After Combined Thoracic Radiotherapy and Osimertinib
por: Smith, Clayton P., et al.
Publicado: (2023)

Early variations in lymphocytes and T lymphocyte subsets are associated with radiation pneumonitis in lung cancer patients and experimental mice received thoracic irradiation
por: Zhou, Pu, et al.
Publicado: (2020)

Pneumonitis and concomitant bacterial pneumonia in patients receiving pembrolizumab treatment: Three case reports and literature review
por: Jun, Jiho, et al.
Publicado: (2019)

Preliminary analysis of the risk factors for radiation pneumonitis in patients with non-small-cell lung cancer treated with concurrent erlotinib and thoracic radiotherapy
por: Zhuang, Hongqing, et al.
Publicado: (2014)

Measurement of exhaled nitric oxide and serum surfactant protein D levels for monitoring radiation pneumonitis following thoracic radiotherapy
por: Yamazaki, Hideya, et al.
Publicado: (2017)

Utilization of serum procalcitonin as a biomarker in the diagnosis and treatment of children with bacterial hospital-acquired pneumonia
por: Wang, Wenlong, et al.
Publicado: (2020)

The Predictive Value of MLR for Radiation Pneumonia During Radiotherapy of Thoracic Tumor Patients
por: Gao, Ya, et al.
Publicado: (2020)

Radiation Recall Pneumonitis: The Open Challenge in Differential Diagnosis of Pneumonia Induced by Oncological Treatments
por: Grassi, Francesca, et al.
Publicado: (2023)

Incidence and risk factors for pneumonitis among patients with lung cancer who received immune checkpoint inhibitors after palliative thoracic radiotherapy
por: Saito, Satoshi, et al.
Publicado: (2021)

Genetic Variants in MTHFR Gene Predict ≥ 2 Radiation Pneumonitis in Esophageal Squamous Cell Carcinoma Patients Treated with Thoracic Radiotherapy
por: Zhang, Yang, et al.
Publicado: (2017)

Relationship between thymidine kinase 1 before radiotherapy and prognosis in breast cancer patients with diabetes
por: Wang, Zhiwu, et al.
Publicado: (2020)

Differential Diagnosis of COVID-19 Pneumonia in Cancer Patients Received Radiotherapy
por: Zeng, Qi, et al.
Publicado: (2020)

Interstitial pneumonitis in a castration-resistant prostate cancer patient receiving cabazitaxel after thoracic radiation therapy: a case report
por: Yanai, Yoshinori, et al.
Publicado: (2019)

Radiation Pneumonitis in Thoracic Cancer Patients: Multi-Center Voxel-Based Analysis
por: Palma, Giuseppe, et al.
Publicado: (2021)

Association of volumetric-modulated arc therapy with radiation pneumonitis in thoracic esophageal cancer
por: Inoo, Hiroyuki, et al.
Publicado: (2022)

Urinary procalcitonin associated with a microbiologically diagnosed pneumonitis: preliminary results
por: Chiappini, F, et al.
Publicado: (1998)

Pre-radiotherapy FDG PET predicts radiation pneumonitis in lung cancer
por: Castillo, Richard, et al.
Publicado: (2014)

Variations of circulating endothelial progenitor cells and transforming growth factor-beta-1 (TGF-β1) during thoracic radiotherapy are predictive for radiation pneumonitis
por: Liu, Yunfang, et al.
Publicado: (2013)

Role of procalcitonin in diagnosis of community acquired pneumonia in Children
por: Ratageri, Vinod H., et al.
Publicado: (2022)

Clinical significance of procalcitonin in critically ill patients with pneumonia receiving bronchoalveolar lavage
por: Li, Lingling, et al.
Publicado: (2022)

Dosiomics and radiomics to predict pneumonitis after thoracic stereotactic body radiotherapy and immune checkpoint inhibition
por: Kraus, Kim Melanie, et al.
Publicado: (2023)

Pneumonitis in cancer patients receiving anti-PD-1 and radiotherapies: Three case reports
por: Lu, Chieh-Sheng, et al.
Publicado: (2017)

The risk and predictors for severe radiation pneumonitis in lung cancer patients treated with thoracic reirradiation
por: Ren, Chengbo, et al.
Publicado: (2018)

Radiation Pneumonitis in Breast Cancer Patients Who Received Radiotherapy Using the Partially Wide Tangent Technique after Breast Conserving Surgery
por: Chung, Yoonsun, et al.
Publicado: (2012)

Effects of Proton Pump Inhibitors on Lung Cancer Precise Radiotherapy-Induced Radiation Pneumonitis
por: Su, QiaoLi, et al.
Publicado: (2014)

Decreased risk of radiation pneumonitis with concurrent use of renin-angiotensin system inhibitors in thoracic radiation therapy of lung cancer
por: Zheng, Yawen, et al.
Publicado: (2023)

Usefulness of Procalcitonin in the Diagnosis of Bacterial Infection in Immunocompetent Children
por: Park, Hae Na, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_c7g08e0ealtpau71s9j2t63ap8